Floatz logo

SUFENTANYL

Thoracic Paravertebral Block

IVO JURISICSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

17 Active assets in the Thoracic Paravertebral Block cohort.

Asset / SponsorPhaseRating
L-Bupivacaine
IVO JURISIC
N/AD
RAMIFENTANYL
IVO JURISIC
N/AD
Epinephrine
IVO JURISIC
N/AD
DEXAMETHASONE
IVO JURISIC
N/AD
Granisetron
IVO JURISIC
N/AD

View all 17 →

Same molecule, other indications

SUFENTANYL is also rated in:

chronic pain syndromeDormant
BB
Indicative ·
69 / 100
View asset →
AnalgesicsDormant
BB
Indicative ·
68 / 100
View asset →
Post Operative PainDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →